The specialty chemicals company reported $1.27 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.22, Zacks reports. Goldman Sachs Group Inc. now owns 484,968 shares of the specialty chemicals company’s stock valued at $37,119,000 after acquiring an additional 202,325 shares during the period. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock worth $16,147,000 after acquiring an additional 168,355 shares during the period. Victory Capital Management Inc. now owns 950,074 shares of the specialty chemicals company’s stock valued at $72,719,000 after purchasing an additional 114,179 shares during the period. About Innospec(Get Free Report)Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio.